Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Stomach Neoplasms × Blood Specimen Collection × Clear all

Phase

Status

Recruiting 4 Unknown 2 Withdrawn 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 46 Neoplasms 31 Colorectal Neoplasms 23 Melanoma 15 Prostatic Neoplasms 13 Neoplastic Cells, Circulating 12 Lung Neoplasms 12 Multiple Myeloma 11 Pancreatic Neoplasms 10 Ovarian Neoplasms 9 Uterine Cervical Neoplasms 8 Carcinoma, Non-Small-Cell Lung 8 Colonic Neoplasms 7 Papillomavirus Infections 6 Neoplasm Metastasis 6 Lymphoma 6 Leukemia, Myeloid, Acute 6 Hematologic Neoplasms 6 Uveal Melanoma 5 Head and Neck Neoplasms 5 Glioma 5 Sarcoma 4 Glioblastoma 4 Disease 4 COVID-19 4 Urinary Bladder Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Rectal Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasms, Plasma Cell 3

Interventions

Cisplatin 105 Oxaliplatin 100 Fluorouracil 88 Capecitabine 84 Docetaxel 62 Leucovorin 55 Irinotecan 52 Paclitaxel 46 S 1 (combination) 36 pembrolizumab 27 Trastuzumab 25 Radiotherapy 24 Bevacizumab 19 titanium silicide 17 Nivolumab 17 Epirubicin 17 Carboplatin 17 Surgical Procedures, Operative 14 Ramucirumab 14 Cetuximab 14 Gastrectomy 13 apatinib 11 Gemcitabine 9 Everolimus 9 Albumin-Bound Paclitaxel 9 Mitomycin 7 Folfox protocol 7 Drug Therapy 7 Cyclophosphamide 7 camrelizumab 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04253106 2024-09-23

LISA-HDGC

Assistance Publique - Hôpitaux de Paris

Phase NA Completed

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡